ID   UBC_HUMAN               Reviewed;         685 AA.
AC   P0CG48; P02248; P02249; P02250; P62988; Q29120; Q6LBL4; Q6LDU5; Q8WYN8;
AC   Q91887; Q91888; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8; Q9UPK7;
DT   10-AUG-2010, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2012, sequence version 3.
DT   26-FEB-2020, entry version 107.
DE   RecName: Full=Polyubiquitin-C;
DE   Contains:
DE     RecName: Full=Ubiquitin;
DE   Flags: Precursor;
GN   Name=UBC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2988935; DOI=10.1002/j.1460-2075.1985.tb03693.x;
RA   Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A., Vuust J.;
RT   "The human ubiquitin multigene family: some genes contain multiple directly
RT   repeated ubiquitin coding sequences.";
RL   EMBO J. 4:755-759(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9644242; DOI=10.1093/oxfordjournals.jbchem.a022093;
RA   Kim N.S., Yamaguchi T., Sekine S., Saeki M., Iwamuro S., Kato S.;
RT   "Cloning of human polyubiquitin cDNAs and a ubiquitin-binding assay
RT   involving its in vitro translation product.";
RL   J. Biochem. 124:35-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14745543; DOI=10.1007/s00239-003-2532-4;
RA   Tachikui H., Saitou N., Nakajima T., Hayasaka I., Ishida T., Inoue I.;
RT   "Lineage-specific homogenization of the polyubiquitin gene among human and
RT   great apes.";
RL   J. Mol. Evol. 57:737-744(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Liver, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-611.
RX   PubMed=8917096; DOI=10.1016/0378-1119(96)00145-x;
RA   Nenoi M., Mita K., Ichimura S., Cartwright I.L., Takahashi E., Yamauchi M.,
RA   Tsuji H.;
RT   "Heterogeneous structure of the polyubiquitin gene UbC of HeLa S3 cells.";
RL   Gene 175:179-185(1996).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-74.
RX   PubMed=1128706; DOI=10.1038/255423a0;
RA   Schlesinger D.H., Goldstein G.;
RT   "Molecular conservation of 74 amino acid sequence of ubiquitin between
RT   cattle and man.";
RL   Nature 255:423-424(1975).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-27; 30-42 AND 55-72, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 1-27 AND 43-54, UBIQUITINATION AT LYS-6; LYS-11 AND
RP   LYS-48, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16443603; DOI=10.1074/jbc.m512786200;
RA   Cripps D., Thomas S.N., Jeng Y., Yang F., Davies P., Yang A.J.;
RT   "Alzheimer disease-specific conformation of hyperphosphorylated paired
RT   helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6
RT   ubiquitin conjugation.";
RL   J. Biol. Chem. 281:10825-10838(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 77-685.
RX   PubMed=9504932;
RA   Nenoi M., Mita K., Ichimura S., Kawano A.;
RT   "Higher frequency of concerted evolutionary events in rodents than in man
RT   at the polyubiquitin gene VNTR locus.";
RL   Genetics 148:867-876(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 417-685.
RX   PubMed=2820408; DOI=10.1016/0006-291x(87)90970-3;
RA   Einspanier R., Sharma H.S., Scheit K.H.;
RT   "Cloning and sequence analysis of a cDNA encoding poly-ubiquitin in human
RT   ovarian granulosa cells.";
RL   Biochem. Biophys. Res. Commun. 147:581-587(1987).
RN   [12]
RP   FUNCTION, UBIQUITINATION AT LYS-11; LYS-29; LYS-48 AND LYS-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16543144; DOI=10.1016/j.molcel.2006.02.018;
RA   Huang F., Kirkpatrick D., Jiang X., Gygi S.P., Sorkin A.;
RT   "Differential regulation of EGF receptor internalization and degradation by
RT   multiubiquitination within the kinase domain.";
RL   Mol. Cell 21:737-748(2006).
RN   [13]
RP   UBIQUITINATION AT LYS-27.
RX   PubMed=15466860; DOI=10.1074/jbc.m402916200;
RA   Okumura F., Hatakeyama S., Matsumoto M., Kamura T., Nakayama K.;
RT   "Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B
RT   contributes to neuritogenesis.";
RL   J. Biol. Chem. 279:53533-53543(2004).
RN   [14]
RP   UBIQUITINATION AT LYS-63, AND MUTAGENESIS OF LYS-48 AND LYS-63.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X., Moinova H.,
RA   Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH
RT   prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [15]
RP   REVIEW, AND FUNCTION.
RX   PubMed=19754430; DOI=10.1042/bst0370937;
RA   Komander D.;
RT   "The emerging complexity of protein ubiquitination.";
RL   Biochem. Soc. Trans. 37:937-953(2009).
RN   [16]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24660806; DOI=10.1042/bj20140334;
RA   Kazlauskaite A., Kondapalli C., Gourlay R., Campbell D.G., Ritorto M.S.,
RA   Hofmann K., Alessi D.R., Knebel A., Trost M., Muqit M.M.;
RT   "Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at
RT   Ser65.";
RL   Biochem. J. 460:127-139(2014).
RN   [17]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24751536; DOI=10.1083/jcb.201402104;
RA   Kane L.A., Lazarou M., Fogel A.I., Li Y., Yamano K., Sarraf S.A.,
RA   Banerjee S., Youle R.J.;
RT   "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase
RT   activity.";
RL   J. Cell Biol. 205:143-153(2014).
RN   [18]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24784582; DOI=10.1038/nature13392;
RA   Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M., Kimura Y.,
RA   Tsuchiya H., Yoshihara H., Hirokawa T., Endo T., Fon E.A., Trempe J.F.,
RA   Saeki Y., Tanaka K., Matsuda N.;
RT   "Ubiquitin is phosphorylated by PINK1 to activate parkin.";
RL   Nature 510:162-166(2014).
RN   [19]
RP   ADP-RIBOSYLATION AT GLY-76, AND MUTAGENESIS OF HIS-68; ARG-72; ARG-74 AND
RP   GLY-76.
RX   PubMed=28525742; DOI=10.1016/j.molcel.2017.04.028;
RA   Yang C.S., Jividen K., Spencer A., Dworak N., Ni L., Oostdyk L.T.,
RA   Chatterjee M., Kusmider B., Reon B., Parlak M., Gorbunova V., Abbas T.,
RA   Jeffery E., Sherman N.E., Paschal B.M.;
RT   "Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase
RT   Dtx3L/Parp9.";
RL   Mol. Cell 66:503-516(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=3041007; DOI=10.1016/0022-2836(87)90679-6;
RA   Vijay-Kumar S., Bugg C.E., Cook W.J.;
RT   "Structure of ubiquitin refined at 1.8-A resolution.";
RL   J. Mol. Biol. 194:531-544(1987).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8166633; DOI=10.1042/bj2990151;
RA   Ramage R., Green J., Muir T.W., Ogunjobi O.M., Love S., Shaw K.;
RT   "Synthetic, structural and biological studies of the ubiquitin system: the
RT   total chemical synthesis of ubiquitin.";
RL   Biochem. J. 299:151-158(1994).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8107144; DOI=10.1006/jmbi.1994.1169;
RA   Cook W.J., Jeffrey L.C., Kasperek E., Pickart C.M.;
RT   "Structure of tetraubiquitin shows how multiubiquitin chains can be
RT   formed.";
RL   J. Mol. Biol. 236:601-609(1994).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=11173499; DOI=10.1107/s090744490001800x;
RA   Phillips C.L., Thrower J., Pickart C.M., Hill C.P.;
RT   "Structure of a new crystal form of tetraubiquitin.";
RL   Acta Crystallogr. D 57:341-344(2001).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP7.
RX   PubMed=12507430; DOI=10.1016/s0092-8674(02)01199-6;
RA   Hu M., Li P., Li M., Li W., Yao T., Wu J.-W., Gu W., Cohen R.E., Shi Y.;
RT   "Crystal structure of a UBP-family deubiquitinating enzyme in isolation and
RT   in complex with ubiquitin aldehyde.";
RL   Cell 111:1041-1054(2002).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP21.
RX   PubMed=21399617; DOI=10.1038/embor.2011.17;
RA   Ye Y., Akutsu M., Reyes-Turcu F., Enchev R.I., Wilkinson K.D., Komander D.;
RT   "Polyubiquitin binding and cross-reactivity in the USP domain
RT   deubiquitinase USP21.";
RL   EMBO Rep. 12:350-357(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-76.
RX   PubMed=20622874; DOI=10.1038/nsmb.1873;
RA   Bremm A., Freund S.M., Komander D.;
RT   "Lys11-linked ubiquitin chains adopt compact conformations and are
RT   preferentially hydrolyzed by the deubiquitinase Cezanne.";
RL   Nat. Struct. Mol. Biol. 17:939-947(2010).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (3.03 ANGSTROMS) OF 1-76 IN COMPLEX WITH YOD1.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F., Freund S.M.,
RA   Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and enable
RT   ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 153-228 PHOSPHORYLATED AT SER-65,
RP   AND PHOSPHORYLATION AT SER-65.
RX   PubMed=25527291; DOI=10.15252/embj.201489847;
RA   Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N.,
RA   Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D.;
RT   "Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain
RT   assembly and hydrolysis.";
RL   EMBO J. 34:307-325(2015).
CC   -!- FUNCTION: [Ubiquitin]: Exists either covalently attached to another
CC       protein, or free (unanchored). When covalently bound, it is conjugated
CC       to target proteins via an isopeptide bond either as a monomer
CC       (monoubiquitin), a polymer linked via different Lys residues of the
CC       ubiquitin (polyubiquitin chains) or a linear polymer linked via the
CC       initiator Met of the ubiquitin (linear polyubiquitin chains).
CC       Polyubiquitin chains, when attached to a target protein, have different
CC       functions depending on the Lys residue of the ubiquitin that is linked:
CC       Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved
CC       in ERAD (endoplasmic reticulum-associated degradation) and in cell-
CC       cycle regulation; Lys-29-linked is involved in lysosomal degradation;
CC       Lys-33-linked is involved in kinase modification; Lys-48-linked is
CC       involved in protein degradation via the proteasome; Lys-63-linked is
CC       involved in endocytosis, DNA-damage responses as well as in signaling
CC       processes leading to activation of the transcription factor NF-kappa-B.
CC       Linear polymer chains formed via attachment by the initiator Met lead
CC       to cell signaling. Ubiquitin is usually conjugated to Lys residues of
CC       target proteins, however, in rare cases, conjugation to Cys or Ser
CC       residues has been observed. When polyubiquitin is free (unanchored-
CC       polyubiquitin), it also has distinct roles, such as in activation of
CC       protein kinases, and in signaling. {ECO:0000269|PubMed:16543144,
CC       ECO:0000269|PubMed:19754430}.
CC   -!- INTERACTION:
CC       Q9UNQ0:ABCG2; NbExp=2; IntAct=EBI-3390054, EBI-1569435;
CC       Q16186:ADRM1; NbExp=10; IntAct=EBI-3390054, EBI-954387;
CC       Q9ULH1:ASAP1; NbExp=2; IntAct=EBI-3390054, EBI-346622;
CC       O43150:ASAP2; NbExp=2; IntAct=EBI-3390054, EBI-310968;
CC       P54252-1:ATXN3; NbExp=2; IntAct=EBI-3390054, EBI-946068;
CC       Q9HB09-1:BCL2L12; NbExp=3; IntAct=EBI-3390054, EBI-6968951;
CC       P35226:BMI1; NbExp=2; IntAct=EBI-3390054, EBI-2341576;
CC       O60566:BUB1B; NbExp=3; IntAct=EBI-3390054, EBI-1001438;
CC       P06493:CDK1; NbExp=6; IntAct=EBI-3390054, EBI-444308;
CC       Q99062:CSF3R; NbExp=2; IntAct=EBI-3390054, EBI-7331284;
CC       Q9UER7:DAXX; NbExp=2; IntAct=EBI-3390054, EBI-77321;
CC       Q15038:DAZAP2; NbExp=4; IntAct=EBI-3390054, EBI-724310;
CC       P40087:DDI1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-5717;
CC       O43583:DENR; NbExp=3; IntAct=EBI-3390054, EBI-716083;
CC       Q6ICB0:DESI1; NbExp=4; IntAct=EBI-3390054, EBI-2806959;
CC       P48510:DSK2 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-6174;
CC       Q86Y01:DTX1; NbExp=2; IntAct=EBI-3390054, EBI-1755174;
CC       Q15717:ELAVL1; NbExp=4; IntAct=EBI-3390054, EBI-374260;
CC       Q61088:Fzd4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7987880;
CC       P25098:GRK2; NbExp=3; IntAct=EBI-3390054, EBI-3904795;
CC       Q9Y6K9:IKBKG; NbExp=4; IntAct=EBI-3390054, EBI-81279;
CC       O88522:Ikbkg (xeno); NbExp=3; IntAct=EBI-3390054, EBI-998011;
CC       Q13887:KLF5; NbExp=2; IntAct=EBI-3390054, EBI-2696013;
CC       P06239:LCK; NbExp=2; IntAct=EBI-3390054, EBI-1348;
CC       P48357-3:LEPR; NbExp=2; IntAct=EBI-3390054, EBI-7886448;
CC       Q9UDY8:MALT1; NbExp=4; IntAct=EBI-3390054, EBI-1047372;
CC       Q9Y6R4:MAP3K4; NbExp=2; IntAct=EBI-3390054, EBI-448104;
CC       O43318:MAP3K7; NbExp=4; IntAct=EBI-3390054, EBI-358684;
CC       Q9NX47:MARCH5; NbExp=2; IntAct=EBI-3390054, EBI-2341610;
CC       Q00987:MDM2; NbExp=6; IntAct=EBI-3390054, EBI-389668;
CC       P01106:MYC; NbExp=5; IntAct=EBI-3390054, EBI-447544;
CC       Q14596:NBR1; NbExp=3; IntAct=EBI-3390054, EBI-742698;
CC       O43639:NCK2; NbExp=2; IntAct=EBI-3390054, EBI-713635;
CC       Q14934:NFATC4; NbExp=3; IntAct=EBI-3390054, EBI-3905796;
CC       P25963:NFKBIA; NbExp=3; IntAct=EBI-3390054, EBI-307386;
CC       P09874:PARP1; NbExp=2; IntAct=EBI-3390054, EBI-355676;
CC       P35227:PCGF2; NbExp=2; IntAct=EBI-3390054, EBI-2129767;
CC       Q9Y253:POLH; NbExp=4; IntAct=EBI-3390054, EBI-2827270;
CC       Q9UNA4:POLI; NbExp=4; IntAct=EBI-3390054, EBI-741774;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-3390054, EBI-1383528;
CC       P55036:PSMD4; NbExp=4; IntAct=EBI-3390054, EBI-359318;
CC       P32628:RAD23 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-14668;
CC       P54727:RAD23B; NbExp=4; IntAct=EBI-3390054, EBI-954531;
CC       Q84L31:RAD23C (xeno); NbExp=2; IntAct=EBI-3390054, EBI-4437395;
CC       Q62921:Rbck1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7266339;
CC       Q96NR8:RDH12; NbExp=2; IntAct=EBI-3390054, EBI-3916363;
CC       Q04206:RELA; NbExp=6; IntAct=EBI-3390054, EBI-73886;
CC       P04325:rev (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7061954;
CC       P55034:RPN10 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-2620423;
CC       O48726:RPN13 (xeno); NbExp=9; IntAct=EBI-3390054, EBI-7710745;
CC       Q8N488:RYBP; NbExp=3; IntAct=EBI-3390054, EBI-752324;
CC       Q9H4L4:SENP3; NbExp=2; IntAct=EBI-3390054, EBI-2880236;
CC       Q96B97:SH3KBP1; NbExp=6; IntAct=EBI-3390054, EBI-346595;
CC       Q9Y5X1:SNX9; NbExp=2; IntAct=EBI-3390054, EBI-77848;
CC       Q13501:SQSTM1; NbExp=3; IntAct=EBI-3390054, EBI-307104;
CC       Q92783:STAM; NbExp=2; IntAct=EBI-3390054, EBI-752333;
CC       Q86VP1:TAX1BP1; NbExp=7; IntAct=EBI-3390054, EBI-529518;
CC       P04637:TP53; NbExp=15; IntAct=EBI-3390054, EBI-366083;
CC       Q9Y4K3:TRAF6; NbExp=3; IntAct=EBI-3390054, EBI-359276;
CC       Q9EPK8:Trpv4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7091763;
CC       P98170:XIAP; NbExp=3; IntAct=EBI-3390054, EBI-517127;
CC       O76080:ZFAND5; NbExp=3; IntAct=EBI-3390054, EBI-8028844;
CC       Q9UGI0:ZRANB1; NbExp=2; IntAct=EBI-3390054, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: [Ubiquitin]: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- PTM: [Ubiquitin]: Phosphorylated at Ser-65 by PINK1 during mitophagy.
CC       Phosphorylated ubiquitin specifically binds and activates parkin
CC       (PRKN), triggering mitophagy (PubMed:24660806, PubMed:24751536,
CC       PubMed:24784582, PubMed:25527291). Phosphorylation does not affect E1-
CC       mediated E2 charging of ubiquitin but affects discharging of E2 enzymes
CC       to form polyubiquitin chains. It also affects deubiquitination by
CC       deubiquitinase enzymes such as USP30 (PubMed:25527291).
CC       {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536,
CC       ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.
CC   -!- PTM: [Ubiquitin]: Mono-ADP-ribosylated at the C-terminus by PARP9, a
CC       component of the PPAR9-DTX3L complex. ADP-ribosylation requires
CC       processing by E1 and E2 enzymes and prevents ubiquitin conjugation to
CC       substrates such as histones. {ECO:0000269|PubMed:28525742}.
CC   -!- MISCELLANEOUS: Ubiquitin is encoded by 4 different genes. UBA52 and
CC       RPS27A genes code for a single copy of ubiquitin fused to the ribosomal
CC       proteins L40 and S27a, respectively. UBB and UBC genes code for a
CC       polyubiquitin precursor with exact head to tail repeats, the number of
CC       repeats differ between species and strains.
CC   -!- MISCELLANEOUS: For the sake of clarity sequence features are annotated
CC       only for the first chain, and are not repeated for each of the
CC       following chains.
CC   -!- SIMILARITY: Belongs to the ubiquitin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M26880; AAA36789.1; -; mRNA.
DR   EMBL; AB009010; BAA23632.1; -; mRNA.
DR   EMBL; AB089613; BAC56951.1; -; Genomic_DNA.
DR   EMBL; AC126309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039193; AAH39193.1; -; mRNA.
DR   EMBL; D63791; BAA09860.1; -; Genomic_DNA.
DR   EMBL; AB003730; BAA23486.1; -; Genomic_DNA.
DR   EMBL; M17597; AAA36787.1; -; mRNA.
DR   CCDS; CCDS9260.1; -.
DR   PIR; A02574; UQHU.
DR   PIR; A22005; UQHUC.
DR   PIR; A29526; A29526.
DR   RefSeq; NP_066289.3; NM_021009.6.
DR   PDB; 1C3T; NMR; -; A=1-76.
DR   PDB; 1CMX; X-ray; 2.25 A; B/D=1-76.
DR   PDB; 1D3Z; NMR; -; A=1-76.
DR   PDB; 1F9J; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 1FXT; NMR; -; B=1-76.
DR   PDB; 1G6J; NMR; -; A=1-76.
DR   PDB; 1GJZ; NMR; -; A/B=1-51.
DR   PDB; 1NBF; X-ray; 2.30 A; C/D=1-76.
DR   PDB; 1OGW; X-ray; 1.32 A; A=1-76.
DR   PDB; 1Q5W; NMR; -; B=1-76.
DR   PDB; 1S1Q; X-ray; 2.00 A; B/D=1-76.
DR   PDB; 1SIF; X-ray; 2.18 A; A=6-76.
DR   PDB; 1TBE; X-ray; 2.40 A; A/B=1-76.
DR   PDB; 1UBI; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UBQ; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UD7; NMR; -; A=1-76.
DR   PDB; 1XD3; X-ray; 1.45 A; B/D=1-75.
DR   PDB; 1XQQ; NMR; -; A=1-76.
DR   PDB; 1YX5; NMR; -; B=1-76.
DR   PDB; 1YX6; NMR; -; B=1-76.
DR   PDB; 1ZGU; NMR; -; B=1-76.
DR   PDB; 1ZO6; Model; -; B/C=1-76.
DR   PDB; 2AYO; X-ray; 3.50 A; B=1-76.
DR   PDB; 2BGF; NMR; -; A/B=1-76.
DR   PDB; 2DEN; NMR; -; B=1-76.
DR   PDB; 2FUH; NMR; -; B=1-76.
DR   PDB; 2G45; X-ray; 1.99 A; B/E=1-76.
DR   PDB; 2GBJ; X-ray; 1.35 A; A/B=1-76.
DR   PDB; 2GBK; X-ray; 1.99 A; A/B/C/D=10-76.
DR   PDB; 2GBM; X-ray; 1.55 A; A/B/C/D=1-76.
DR   PDB; 2GBN; X-ray; 1.60 A; A=1-76.
DR   PDB; 2GBR; X-ray; 2.00 A; A/B/C=1-76.
DR   PDB; 2GMI; X-ray; 2.50 A; C=1-76.
DR   PDB; 2HTH; X-ray; 2.70 A; A=1-76.
DR   PDB; 2IBI; X-ray; 2.20 A; B=1-75.
DR   PDB; 2J7Q; X-ray; 1.80 A; B/D=1-75.
DR   PDB; 2JF5; X-ray; 1.95 A; A/B=1-76.
DR   PDB; 2JRI; NMR; -; B/C=1-76.
DR   PDB; 2JY6; NMR; -; A=1-76.
DR   PDB; 2JZZ; NMR; -; A=1-76.
DR   PDB; 2K25; NMR; -; A=1-75.
DR   PDB; 2K6D; NMR; -; B=1-75.
DR   PDB; 2K8B; NMR; -; A=1-76.
DR   PDB; 2K8C; NMR; -; A=1-76.
DR   PDB; 2KDF; NMR; -; B/C=1-76.
DR   PDB; 2KHW; NMR; -; B=1-76.
DR   PDB; 2KJH; NMR; -; B=1-75.
DR   PDB; 2KLG; NMR; -; A=1-76.
DR   PDB; 2KN5; NMR; -; A=1-76.
DR   PDB; 2KX0; NMR; -; A=74-151.
DR   PDB; 2L3Z; NMR; -; A=1-76.
DR   PDB; 2LD9; NMR; -; A=76-152.
DR   PDB; 2LVO; NMR; -; A=1-76.
DR   PDB; 2LVP; NMR; -; A/B=1-76.
DR   PDB; 2LVQ; NMR; -; A/B=1-76.
DR   PDB; 2LZ6; NMR; -; A=609-684.
DR   PDB; 2MBO; NMR; -; A/B=609-684.
DR   PDB; 2MBQ; NMR; -; A/B=609-684.
DR   PDB; 2MCN; NMR; -; B=609-684.
DR   PDB; 2MI8; NMR; -; A=609-684.
DR   PDB; 2MJ5; NMR; -; A=609-684.
DR   PDB; 2MOR; NMR; -; A=609-684.
DR   PDB; 2MRE; NMR; -; A=609-684.
DR   PDB; 2MWS; NMR; -; A=609-684.
DR   PDB; 2N2K; NMR; -; A=609-684, B=609-679.
DR   PDB; 2NR2; NMR; -; A=1-76.
DR   PDB; 2O6V; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 2OJR; X-ray; 2.60 A; A=1-76.
DR   PDB; 2PE9; NMR; -; A/B=1-76.
DR   PDB; 2PEA; NMR; -; A/B=1-76.
DR   PDB; 2RR9; NMR; -; A/B=1-76.
DR   PDB; 2RU6; NMR; -; A=609-684.
DR   PDB; 2W9N; X-ray; 2.25 A; A=1-152.
DR   PDB; 2WDT; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 2XEW; X-ray; 2.20 A; A/B/C/D/E/F/G/H/I/J/K/L=1-76.
DR   PDB; 2Y5B; X-ray; 2.70 A; B/F=1-152.
DR   PDB; 2Z59; NMR; -; B=1-76.
DR   PDB; 2ZCB; X-ray; 1.60 A; A/B/C=1-76.
DR   PDB; 2ZVN; X-ray; 3.00 A; A/C/E/G=1-152.
DR   PDB; 2ZVO; X-ray; 2.90 A; A/G=1-152.
DR   PDB; 3A33; X-ray; 2.20 A; B=1-76.
DR   PDB; 3ALB; X-ray; 1.85 A; A/B/C/D=1-76.
DR   PDB; 3AUL; X-ray; 2.39 A; A/B=1-76.
DR   PDB; 3B08; X-ray; 1.70 A; A/D/G/J=1-152.
DR   PDB; 3B0A; X-ray; 1.90 A; A/D=1-152.
DR   PDB; 3BY4; X-ray; 1.55 A; B=1-75.
DR   PDB; 3C0R; X-ray; 2.31 A; B/D=1-75.
DR   PDB; 3DVG; X-ray; 2.60 A; X/Y=1-76.
DR   PDB; 3DVN; X-ray; 2.70 A; U/V/X/Y=1-76.
DR   PDB; 3EEC; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3EFU; X-ray; 1.84 A; A=1-76.
DR   PDB; 3EHV; X-ray; 1.81 A; A/B/C=1-76.
DR   PDB; 3H7P; X-ray; 1.90 A; A/B=1-76.
DR   PDB; 3H7S; X-ray; 2.30 A; A/B=1-76.
DR   PDB; 3HM3; X-ray; 1.96 A; A/B/C/D=1-76.
DR   PDB; 3I3T; X-ray; 2.59 A; B/D/F/H=1-75.
DR   PDB; 3IFW; X-ray; 2.40 A; B=1-75.
DR   PDB; 3IHP; X-ray; 2.80 A; C/D=1-75.
DR   PDB; 3JSV; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 3JVZ; X-ray; 3.30 A; X/Y=1-76.
DR   PDB; 3JW0; X-ray; 3.10 A; X/Y=1-76.
DR   PDB; 3K9O; X-ray; 1.80 A; B=76-151.
DR   PDB; 3K9P; X-ray; 2.80 A; B=1-76.
DR   PDB; 3KVF; X-ray; 2.80 A; B=1-75.
DR   PDB; 3KW5; X-ray; 2.83 A; B=1-75.
DR   PDB; 3LDZ; X-ray; 2.60 A; E/F/G=1-73.
DR   PDB; 3MHS; X-ray; 1.89 A; D=1-76.
DR   PDB; 3MTN; X-ray; 2.70 A; B/D=1-76.
DR   PDB; 3N30; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3N32; X-ray; 1.80 A; A=1-76.
DR   PDB; 3N3K; X-ray; 2.60 A; B=5-76.
DR   PDB; 3NS8; X-ray; 1.71 A; A/B=1-76.
DR   PDB; 3O65; X-ray; 2.70 A; B/D/F/H=1-75.
DR   PDB; 3OFI; X-ray; 2.35 A; C/D=1-76.
DR   PDB; 3OJ3; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 3OJ4; X-ray; 3.40 A; B/E=1-76.
DR   PDB; 3ONS; X-ray; 1.80 A; A=1-72.
DR   PDB; 3PRM; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 3PT2; X-ray; 2.50 A; B=1-75.
DR   PDB; 3PTF; X-ray; 2.70 A; C/D=1-76.
DR   PDB; 3Q3F; X-ray; 2.17 A; A=2-76.
DR   PDB; 3RUL; X-ray; 2.50 A; A/B/C/D=1-75.
DR   PDB; 3TMP; X-ray; 1.91 A; B/D/F/H=1-76.
DR   PDB; 3U30; X-ray; 2.43 A; A/D=1-152.
DR   PDB; 3UGB; X-ray; 2.35 A; B=1-76.
DR   PDB; 3V6C; X-ray; 1.70 A; B=74-150.
DR   PDB; 3V6E; X-ray; 2.10 A; B=74-150.
DR   PDB; 3VFK; X-ray; 2.80 A; A=1-75.
DR   PDB; 3VUW; X-ray; 1.95 A; A/B/C=1-76.
DR   PDB; 3VUX; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 3VUY; X-ray; 1.98 A; A/B/C=1-76.
DR   PDB; 3WXE; X-ray; 2.50 A; B=533-680.
DR   PDB; 3WXF; X-ray; 2.30 A; B/D=533-680.
DR   PDB; 3ZLZ; X-ray; 2.90 A; A/B=1-76.
DR   PDB; 3ZNH; X-ray; 2.30 A; B=1-75.
DR   PDB; 3ZNI; X-ray; 2.21 A; D/H/L/P=1-76.
DR   PDB; 3ZNZ; X-ray; 1.90 A; B=1-152.
DR   PDB; 4AP4; X-ray; 2.21 A; C/F=608-684.
DR   PDB; 4AUQ; X-ray; 2.18 A; C/F=1-76.
DR   PDB; 4BOS; X-ray; 2.35 A; C/E=609-684, F=612-625.
DR   PDB; 4BOZ; X-ray; 3.03 A; B/C/E=1-76.
DR   PDB; 4BVU; X-ray; 2.70 A; C=609-684.
DR   PDB; 4DDG; X-ray; 3.30 A; D/E/F/G/H/I/M/N/O/P/Q/R=1-76.
DR   PDB; 4DDI; X-ray; 3.80 A; G/H/I/J/K/L=1-76.
DR   PDB; 4DHJ; X-ray; 2.35 A; B/F/J/M=1-76, D/H=1-75.
DR   PDB; 4DHZ; X-ray; 3.11 A; B=1-76, E=1-75.
DR   PDB; 4FJV; X-ray; 2.05 A; B/D=1-76.
DR   PDB; 4HK2; X-ray; 1.40 A; A/B/C/D=1-76.
DR   PDB; 4HXD; X-ray; 2.85 A; A/C=1-75.
DR   PDB; 4I6L; X-ray; 2.49 A; B=77-150.
DR   PDB; 4I6N; X-ray; 1.70 A; B/D=1-75.
DR   PDB; 4IG7; X-ray; 2.00 A; B=1-75.
DR   PDB; 4IUM; X-ray; 1.45 A; B=1-75.
DR   PDB; 4JQW; X-ray; 2.90 A; C=609-684.
DR   PDB; 4K1R; X-ray; 1.63 A; B/D=607-684.
DR   PDB; 4K7S; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7U; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7W; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4KSK; X-ray; 2.40 A; C/D=76-152.
DR   PDB; 4KSL; X-ray; 2.83 A; C/D/F/H/J/L/N/P/R/T/V/X=76-228.
DR   PDB; 4LCD; X-ray; 3.10 A; E/F=609-683.
DR   PDB; 4LDT; X-ray; 1.90 A; B/D=609-684.
DR   PDB; 4MDK; X-ray; 2.61 A; E/F/G/H=608-684.
DR   PDB; 4MM3; X-ray; 2.75 A; A=609-684.
DR   PDB; 4MSM; X-ray; 1.74 A; B/D=609-684.
DR   PDB; 4MSQ; X-ray; 1.95 A; B/D=609-684.
DR   PDB; 4NQK; X-ray; 3.70 A; E/F/G/H/I/J=608-684.
DR   PDB; 4UN2; X-ray; 1.51 A; A=609-684.
DR   PDB; 4V3K; X-ray; 2.04 A; B/E=609-684.
DR   PDB; 4V3L; X-ray; 1.53 A; B/D=609-684.
DR   PDB; 4WZP; X-ray; 1.90 A; A/B/C/D/E/F/G/H=153-228.
DR   PDB; 4XOK; X-ray; 2.20 A; A/B/C=1-76.
DR   PDB; 4XOL; X-ray; 2.91 A; A/B=1-76.
DR   PDB; 4ZQS; X-ray; 1.80 A; A/B=533-684.
DR   PDB; 5A5B; EM; 9.50 A; 9=609-684.
DR   PDB; 5AF4; X-ray; 1.85 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 5AF5; X-ray; 1.68 A; A=1-73.
DR   PDB; 5AF6; X-ray; 3.40 A; A/B/C/D/E=1-76.
DR   PDB; 5AIT; X-ray; 3.40 A; C/F=609-684.
DR   PDB; 5AIU; X-ray; 2.21 A; C/F=609-684.
DR   PDB; 5B83; X-ray; 2.69 A; A/D=1-304.
DR   PDB; 5C7J; X-ray; 3.00 A; C/D=1-74.
DR   PDB; 5C7M; X-ray; 3.03 A; B/C=1-75.
DR   PDB; 5E6J; X-ray; 2.85 A; B/E=609-683.
DR   PDB; 5H07; X-ray; 2.59 A; A=1-228.
DR   PDB; 5NL4; X-ray; 1.32 A; A/B/C=1-76.
DR   PDB; 5NLF; X-ray; 1.50 A; A/B/C=1-76.
DR   PDB; 5NLI; X-ray; 1.53 A; A/B/C=1-76.
DR   PDB; 5NMC; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 5OE7; X-ray; 2.95 A; B=1-146.
DR   PDB; 5OHV; X-ray; 2.80 A; A/C=1-76.
DR   PDB; 5OXH; X-ray; 1.60 A; A=1-76.
DR   PDB; 5OXI; X-ray; 1.63 A; A/B=1-76.
DR   PDB; 5UDH; X-ray; 3.24 A; E=1-76.
DR   PDB; 5WQ4; X-ray; 3.00 A; A/B=1-152.
DR   PDB; 5ZQ3; X-ray; 2.18 A; C/D=609-684.
DR   PDB; 5ZQ4; X-ray; 2.22 A; C/D=609-684.
DR   PDB; 5ZQ5; X-ray; 2.49 A; B/D=609-684.
DR   PDB; 5ZQ6; X-ray; 3.01 A; B/D=609-684.
DR   PDB; 5ZQ7; X-ray; 2.85 A; B/D=609-684.
DR   PDB; 6A43; X-ray; 2.40 A; A=1-76.
DR   PDB; 6A44; X-ray; 2.40 A; A=1-76.
DR   PDB; 6AQR; X-ray; 2.10 A; D=609-684.
DR   PDB; 6B7M; X-ray; 1.70 A; B/C=609-684.
DR   PDB; 6B7O; X-ray; 1.85 A; B/C=609-684.
DR   PDB; 6EQI; X-ray; 3.10 A; A=1-76.
DR   PDB; 6N13; NMR; -; A=1-76.
DR   PDB; 6N6R; X-ray; 1.95 A; A/C=1-76.
DR   PDB; 6NQA; EM; 3.54 A; L=1-76.
DR   PDB; 6OI4; X-ray; 1.76 A; C/D=1-76.
DR   PDB; 6RYA; X-ray; 2.21 A; B/D/F=1-76.
DR   PDB; 6S53; X-ray; 2.80 A; D/F/J/L=1-76.
DR   PDBsum; 1C3T; -.
DR   PDBsum; 1CMX; -.
DR   PDBsum; 1D3Z; -.
DR   PDBsum; 1F9J; -.
DR   PDBsum; 1FXT; -.
DR   PDBsum; 1G6J; -.
DR   PDBsum; 1GJZ; -.
DR   PDBsum; 1NBF; -.
DR   PDBsum; 1OGW; -.
DR   PDBsum; 1Q5W; -.
DR   PDBsum; 1S1Q; -.
DR   PDBsum; 1SIF; -.
DR   PDBsum; 1TBE; -.
DR   PDBsum; 1UBI; -.
DR   PDBsum; 1UBQ; -.
DR   PDBsum; 1UD7; -.
DR   PDBsum; 1XD3; -.
DR   PDBsum; 1XQQ; -.
DR   PDBsum; 1YX5; -.
DR   PDBsum; 1YX6; -.
DR   PDBsum; 1ZGU; -.
DR   PDBsum; 1ZO6; -.
DR   PDBsum; 2AYO; -.
DR   PDBsum; 2BGF; -.
DR   PDBsum; 2DEN; -.
DR   PDBsum; 2FUH; -.
DR   PDBsum; 2G45; -.
DR   PDBsum; 2GBJ; -.
DR   PDBsum; 2GBK; -.
DR   PDBsum; 2GBM; -.
DR   PDBsum; 2GBN; -.
DR   PDBsum; 2GBR; -.
DR   PDBsum; 2GMI; -.
DR   PDBsum; 2HTH; -.
DR   PDBsum; 2IBI; -.
DR   PDBsum; 2J7Q; -.
DR   PDBsum; 2JF5; -.
DR   PDBsum; 2JRI; -.
DR   PDBsum; 2JY6; -.
DR   PDBsum; 2JZZ; -.
DR   PDBsum; 2K25; -.
DR   PDBsum; 2K6D; -.
DR   PDBsum; 2K8B; -.
DR   PDBsum; 2K8C; -.
DR   PDBsum; 2KDF; -.
DR   PDBsum; 2KHW; -.
DR   PDBsum; 2KJH; -.
DR   PDBsum; 2KLG; -.
DR   PDBsum; 2KN5; -.
DR   PDBsum; 2KX0; -.
DR   PDBsum; 2L3Z; -.
DR   PDBsum; 2LD9; -.
DR   PDBsum; 2LVO; -.
DR   PDBsum; 2LVP; -.
DR   PDBsum; 2LVQ; -.
DR   PDBsum; 2LZ6; -.
DR   PDBsum; 2MBO; -.
DR   PDBsum; 2MBQ; -.
DR   PDBsum; 2MCN; -.
DR   PDBsum; 2MI8; -.
DR   PDBsum; 2MJ5; -.
DR   PDBsum; 2MOR; -.
DR   PDBsum; 2MRE; -.
DR   PDBsum; 2MWS; -.
DR   PDBsum; 2N2K; -.
DR   PDBsum; 2NR2; -.
DR   PDBsum; 2O6V; -.
DR   PDBsum; 2OJR; -.
DR   PDBsum; 2PE9; -.
DR   PDBsum; 2PEA; -.
DR   PDBsum; 2RR9; -.
DR   PDBsum; 2RU6; -.
DR   PDBsum; 2W9N; -.
DR   PDBsum; 2WDT; -.
DR   PDBsum; 2XEW; -.
DR   PDBsum; 2Y5B; -.
DR   PDBsum; 2Z59; -.
DR   PDBsum; 2ZCB; -.
DR   PDBsum; 2ZVN; -.
DR   PDBsum; 2ZVO; -.
DR   PDBsum; 3A33; -.
DR   PDBsum; 3ALB; -.
DR   PDBsum; 3AUL; -.
DR   PDBsum; 3B08; -.
DR   PDBsum; 3B0A; -.
DR   PDBsum; 3BY4; -.
DR   PDBsum; 3C0R; -.
DR   PDBsum; 3DVG; -.
DR   PDBsum; 3DVN; -.
DR   PDBsum; 3EEC; -.
DR   PDBsum; 3EFU; -.
DR   PDBsum; 3EHV; -.
DR   PDBsum; 3H7P; -.
DR   PDBsum; 3H7S; -.
DR   PDBsum; 3HM3; -.
DR   PDBsum; 3I3T; -.
DR   PDBsum; 3IFW; -.
DR   PDBsum; 3IHP; -.
DR   PDBsum; 3JSV; -.
DR   PDBsum; 3JVZ; -.
DR   PDBsum; 3JW0; -.
DR   PDBsum; 3K9O; -.
DR   PDBsum; 3K9P; -.
DR   PDBsum; 3KVF; -.
DR   PDBsum; 3KW5; -.
DR   PDBsum; 3LDZ; -.
DR   PDBsum; 3MHS; -.
DR   PDBsum; 3MTN; -.
DR   PDBsum; 3N30; -.
DR   PDBsum; 3N32; -.
DR   PDBsum; 3N3K; -.
DR   PDBsum; 3NS8; -.
DR   PDBsum; 3O65; -.
DR   PDBsum; 3OFI; -.
DR   PDBsum; 3OJ3; -.
DR   PDBsum; 3OJ4; -.
DR   PDBsum; 3ONS; -.
DR   PDBsum; 3PRM; -.
DR   PDBsum; 3PT2; -.
DR   PDBsum; 3PTF; -.
DR   PDBsum; 3Q3F; -.
DR   PDBsum; 3RUL; -.
DR   PDBsum; 3TMP; -.
DR   PDBsum; 3U30; -.
DR   PDBsum; 3UGB; -.
DR   PDBsum; 3V6C; -.
DR   PDBsum; 3V6E; -.
DR   PDBsum; 3VFK; -.
DR   PDBsum; 3VUW; -.
DR   PDBsum; 3VUX; -.
DR   PDBsum; 3VUY; -.
DR   PDBsum; 3WXE; -.
DR   PDBsum; 3WXF; -.
DR   PDBsum; 3ZLZ; -.
DR   PDBsum; 3ZNH; -.
DR   PDBsum; 3ZNI; -.
DR   PDBsum; 3ZNZ; -.
DR   PDBsum; 4AP4; -.
DR   PDBsum; 4AUQ; -.
DR   PDBsum; 4BOS; -.
DR   PDBsum; 4BOZ; -.
DR   PDBsum; 4BVU; -.
DR   PDBsum; 4DDG; -.
DR   PDBsum; 4DDI; -.
DR   PDBsum; 4DHJ; -.
DR   PDBsum; 4DHZ; -.
DR   PDBsum; 4FJV; -.
DR   PDBsum; 4HK2; -.
DR   PDBsum; 4HXD; -.
DR   PDBsum; 4I6L; -.
DR   PDBsum; 4I6N; -.
DR   PDBsum; 4IG7; -.
DR   PDBsum; 4IUM; -.
DR   PDBsum; 4JQW; -.
DR   PDBsum; 4K1R; -.
DR   PDBsum; 4K7S; -.
DR   PDBsum; 4K7U; -.
DR   PDBsum; 4K7W; -.
DR   PDBsum; 4KSK; -.
DR   PDBsum; 4KSL; -.
DR   PDBsum; 4LCD; -.
DR   PDBsum; 4LDT; -.
DR   PDBsum; 4MDK; -.
DR   PDBsum; 4MM3; -.
DR   PDBsum; 4MSM; -.
DR   PDBsum; 4MSQ; -.
DR   PDBsum; 4NQK; -.
DR   PDBsum; 4UN2; -.
DR   PDBsum; 4V3K; -.
DR   PDBsum; 4V3L; -.
DR   PDBsum; 4WZP; -.
DR   PDBsum; 4XOK; -.
DR   PDBsum; 4XOL; -.
DR   PDBsum; 4ZQS; -.
DR   PDBsum; 5A5B; -.
DR   PDBsum; 5AF4; -.
DR   PDBsum; 5AF5; -.
DR   PDBsum; 5AF6; -.
DR   PDBsum; 5AIT; -.
DR   PDBsum; 5AIU; -.
DR   PDBsum; 5B83; -.
DR   PDBsum; 5C7J; -.
DR   PDBsum; 5C7M; -.
DR   PDBsum; 5E6J; -.
DR   PDBsum; 5H07; -.
DR   PDBsum; 5NL4; -.
DR   PDBsum; 5NLF; -.
DR   PDBsum; 5NLI; -.
DR   PDBsum; 5NMC; -.
DR   PDBsum; 5OE7; -.
DR   PDBsum; 5OHV; -.
DR   PDBsum; 5OXH; -.
DR   PDBsum; 5OXI; -.
DR   PDBsum; 5UDH; -.
DR   PDBsum; 5WQ4; -.
DR   PDBsum; 5ZQ3; -.
DR   PDBsum; 5ZQ4; -.
DR   PDBsum; 5ZQ5; -.
DR   PDBsum; 5ZQ6; -.
DR   PDBsum; 5ZQ7; -.
DR   PDBsum; 6A43; -.
DR   PDBsum; 6A44; -.
DR   PDBsum; 6AQR; -.
DR   PDBsum; 6B7M; -.
DR   PDBsum; 6B7O; -.
DR   PDBsum; 6EQI; -.
DR   PDBsum; 6N13; -.
DR   PDBsum; 6N6R; -.
DR   PDBsum; 6NQA; -.
DR   PDBsum; 6OI4; -.
DR   PDBsum; 6RYA; -.
DR   PDBsum; 6S53; -.
DR   SMR; P0CG48; -.
DR   BioGrid; 113164; 1645.
DR   IntAct; P0CG48; 188.
DR   MINT; P0CG48; -.
DR   STRING; 9606.ENSP00000441543; -.
DR   DrugBank; DB04464; N-Formylmethionine.
DR   MoonDB; P0CG48; Predicted.
DR   iPTMnet; P0CG48; -.
DR   PhosphoSitePlus; P0CG48; -.
DR   SwissPalm; P0CG48; -.
DR   BioMuta; UBC; -.
DR   DMDM; 391358178; -.
DR   EPD; P0CG48; -.
DR   jPOST; P0CG48; -.
DR   MassIVE; P0CG48; -.
DR   MaxQB; P0CG48; -.
DR   PaxDb; P0CG48; -.
DR   PeptideAtlas; P0CG48; -.
DR   PRIDE; P0CG48; -.
DR   ProteomicsDB; 52475; -.
DR   TopDownProteomics; P0CG48; -.
DR   ABCD; P0CG48; -.
DR   Ensembl; ENST00000339647; ENSP00000344818; ENSG00000150991.
DR   Ensembl; ENST00000536769; ENSP00000441543; ENSG00000150991.
DR   GeneID; 7316; -.
DR   KEGG; hsa:7316; -.
DR   UCSC; uc001ugs.5; human.
DR   CTD; 7316; -.
DR   DisGeNET; 7316; -.
DR   GeneCards; UBC; -.
DR   HGNC; HGNC:12468; UBC.
DR   HPA; CAB000362; -.
DR   HPA; CAB005419; -.
DR   HPA; HPA041344; -.
DR   HPA; HPA049132; -.
DR   MIM; 191340; gene.
DR   neXtProt; NX_P0CG48; -.
DR   OpenTargets; ENSG00000150991; -.
DR   eggNOG; KOG0001; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   GeneTree; ENSGT00940000163900; -.
DR   HOGENOM; CLU_010412_1_1_1; -.
DR   InParanoid; P0CG48; -.
DR   KO; K08770; -.
DR   OMA; TTINIKY; -.
DR   OrthoDB; 1536766at2759; -.
DR   TreeFam; TF354256; -.
DR   Reactome; R-HSA-110312; Translesion synthesis by REV1.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-110320; Translesion Synthesis by POLH.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168927; TICAM1, RIP1-mediated IKK complex recruitment.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-174490; Membrane binding and targetting of GAG proteins.
DR   Reactome; R-HSA-175474; Assembly Of The HIV Virion.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-HSA-209560; NF-kB is activated and signals survival.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3134975; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
DR   Reactome; R-HSA-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-HSA-5205685; Pink/Parkin Mediated Mitophagy.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-HSA-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-HSA-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-HSA-5655862; Translesion synthesis by POLK.
DR   Reactome; R-HSA-5656121; Translesion synthesis by POLI.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5684264; MAP3K8 (TPL2)-dependent MAPK1/3 activation.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689877; Josephin domain DUBs.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69541; Stabilization of p53.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-75815; Ubiquitin-dependent degradation of Cyclin D.
DR   Reactome; R-HSA-8849469; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   Reactome; R-HSA-8876493; InlA-mediated entry of Listeria monocytogenes into host cells.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948747; Regulation of PTEN localization.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9013973; TICAM1-dependent activation of IRF3/IRF7.
DR   Reactome; R-HSA-9014325; TICAM1,TRAF6-dependent induction of TAK1 complex.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   Reactome; R-HSA-936964; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon.
DR   Reactome; R-HSA-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-HSA-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-HSA-9604323; Negative regulation of NOTCH4 signaling.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   Reactome; R-HSA-9615710; Microautophagy.
DR   Reactome; R-HSA-9645460; Alpha-protein kinase 1 signaling pathway.
DR   Reactome; R-HSA-975110; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling.
DR   Reactome; R-HSA-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; P0CG48; -.
DR   ChiTaRS; UBC; human.
DR   EvolutionaryTrace; P0CG48; -.
DR   GeneWiki; Ubiquitin_C; -.
DR   GenomeRNAi; 7316; -.
DR   Pharos; P0CG48; Tbio.
DR   PRO; PR:P0CG48; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P0CG48; protein.
DR   Bgee; ENSG00000150991; Expressed in Brodmann (1909) area 46 and 238 other tissues.
DR   ExpressionAtlas; P0CG48; baseline and differential.
DR   Genevisible; P0CG48; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0031386; F:protein tag; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0016197; P:endosomal transport; TAS:Reactome.
DR   GO; GO:0070987; P:error-free translesion synthesis; TAS:Reactome.
DR   GO; GO:0042276; P:error-prone translesion synthesis; TAS:Reactome.
DR   GO; GO:0070911; P:global genome nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0036297; P:interstrand cross-link repair; TAS:Reactome.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007254; P:JNK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0019941; P:modification-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome.
DR   GO; GO:0000715; P:nucleotide-excision repair, DNA damage recognition; TAS:Reactome.
DR   GO; GO:0000717; P:nucleotide-excision repair, DNA duplex unwinding; TAS:Reactome.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0006294; P:nucleotide-excision repair, preincision complex assembly; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006625; P:protein targeting to peroxisome; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   GO; GO:0019068; P:virion assembly; TAS:Reactome.
DR   GO; GO:0016055; P:Wnt signaling pathway; TAS:Reactome.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR019956; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 9.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 9.
DR   SUPFAM; SSF54236; SSF54236; 9.
DR   PROSITE; PS00299; UBIQUITIN_1; 9.
DR   PROSITE; PS50053; UBIQUITIN_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Cytoplasm; Direct protein sequencing;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   CHAIN           1..76
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396178"
FT   CHAIN           77..152
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396179"
FT   CHAIN           153..228
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396180"
FT   CHAIN           229..304
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396181"
FT   CHAIN           305..380
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396182"
FT   CHAIN           381..456
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396183"
FT   CHAIN           457..532
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396184"
FT   CHAIN           533..608
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396185"
FT   CHAIN           609..684
FT                   /note="Ubiquitin"
FT                   /id="PRO_0000396186"
FT   PROPEP          685
FT                   /id="PRO_0000396187"
FT   DOMAIN          1..76
FT                   /note="Ubiquitin-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          77..152
FT                   /note="Ubiquitin-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          153..228
FT                   /note="Ubiquitin-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          229..304
FT                   /note="Ubiquitin-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          305..380
FT                   /note="Ubiquitin-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          381..456
FT                   /note="Ubiquitin-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          457..532
FT                   /note="Ubiquitin-like 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          533..608
FT                   /note="Ubiquitin-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          609..684
FT                   /note="Ubiquitin-like 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   BINDING         54
FT                   /note="Activating enzyme"
FT   BINDING         72
FT                   /note="Activating enzyme"
FT   SITE            68
FT                   /note="Essential for function"
FT   MOD_RES         65
FT                   /note="Phosphoserine; by PINK1"
FT                   /evidence="ECO:0000269|PubMed:24660806,
FT                   ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582,
FT                   ECO:0000269|PubMed:25527291"
FT   MOD_RES         76
FT                   /note="ADP-ribosylglycine"
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16443603"
FT   CROSSLNK        11
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16443603,
FT                   ECO:0000269|PubMed:16543144"
FT   CROSSLNK        27
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:15466860"
FT   CROSSLNK        29
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16543144"
FT   CROSSLNK        48
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16443603,
FT                   ECO:0000269|PubMed:16543144"
FT   CROSSLNK        63
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16543144,
FT                   ECO:0000269|PubMed:18719106"
FT   CROSSLNK        76
FT                   /note="Glycyl lysine isopeptide (Gly-Lys) (interchain with
FT                   K-? in acceptor proteins)"
FT   MUTAGEN         48
FT                   /note="K->R: No effect on HLTF-mediated polyubiquitination
FT                   of PCNA."
FT                   /evidence="ECO:0000269|PubMed:18719106"
FT   MUTAGEN         63
FT                   /note="K->R: Abolishes HLTF-mediated polyubiquitination of
FT                   PCNA."
FT                   /evidence="ECO:0000269|PubMed:18719106"
FT   MUTAGEN         65
FT                   /note="S->A: Prevents phosphorylation in case of
FT                   mitophagy."
FT                   /evidence="ECO:0000269|PubMed:24660806,
FT                   ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582"
FT   MUTAGEN         65
FT                   /note="S->D: Phosphomimetic mutant that binds and activates
FT                   PRKN."
FT                   /evidence="ECO:0000269|PubMed:24751536"
FT   MUTAGEN         68
FT                   /note="H->G: Loss of DTX3L-mediated polyubiquitination of
FT                   histone H3 and H4."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         72
FT                   /note="R->G: No effect on ADP-ribosylation."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         72
FT                   /note="R->K: No effect on ADP-ribosylation, when associated
FT                   with K-74."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         74
FT                   /note="R->G: No effect on ADP-ribosylation."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         74
FT                   /note="R->K: No effect on ADP-ribosylation, when associated
FT                   with K-72."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   MUTAGEN         76
FT                   /note="G->A: Loss of ADP-ribosylation."
FT                   /evidence="ECO:0000269|PubMed:28525742"
FT   CONFLICT        190
FT                   /note="P -> S (in Ref. 4; AC126309)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        397
FT                   /note="V -> G (in Ref. 6; BAA09860)"
FT                   /evidence="ECO:0000305"
FT   STRAND          383..386
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   STRAND          392..395
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   HELIX           403..411
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   HELIX           418..420
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   STRAND          421..425
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   STRAND          428..430
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   HELIX           436..438
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   STRAND          446..451
FT                   /evidence="ECO:0000244|PDB:5B83"
FT   STRAND          458..463
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   STRAND          468..472
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   HELIX           479..490
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   HELIX           494..496
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   STRAND          497..501
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   HELIX           513..515
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   STRAND          522..527
FT                   /evidence="ECO:0000244|PDB:5H07"
FT   STRAND          534..539
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   STRAND          540..542
FT                   /evidence="ECO:0000244|PDB:6N6R"
FT   STRAND          544..548
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   HELIX           555..566
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   HELIX           570..572
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   STRAND          573..577
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   STRAND          579..581
FT                   /evidence="ECO:0000244|PDB:3N3K"
FT   STRAND          586..588
FT                   /evidence="ECO:0000244|PDB:6N6R"
FT   HELIX           589..591
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   STRAND          598..603
FT                   /evidence="ECO:0000244|PDB:3B08"
FT   STRAND          610..615
FT                   /evidence="ECO:0000244|PDB:1OGW"
FT   STRAND          616..618
FT                   /evidence="ECO:0000244|PDB:4K1R"
FT   STRAND          620..624
FT                   /evidence="ECO:0000244|PDB:1OGW"
FT   STRAND          627..630
FT                   /evidence="ECO:0000244|PDB:1G6J"
FT   HELIX           631..642
FT                   /evidence="ECO:0000244|PDB:1OGW"
FT   HELIX           646..648
FT                   /evidence="ECO:0000244|PDB:1OGW"
FT   STRAND          649..653
FT                   /evidence="ECO:0000244|PDB:1OGW"
FT   STRAND          654..657
FT                   /evidence="ECO:0000244|PDB:4BVU"
FT   STRAND          660..663
FT                   /evidence="ECO:0000244|PDB:6B7O"
FT   HELIX           664..667
FT                   /evidence="ECO:0000244|PDB:1OGW"
FT   TURN            668..670
FT                   /evidence="ECO:0000244|PDB:5OXH"
FT   STRAND          671..673
FT                   /evidence="ECO:0000244|PDB:6EQI"
FT   STRAND          674..679
FT                   /evidence="ECO:0000244|PDB:1OGW"
SQ   SEQUENCE   685 AA;  77039 MW;  B6E7BC06FEE77196 CRC64;
     MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ QRLIFAGKQL EDGRTLSDYN
     IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE NVKAKIQDKE GIPPDQQRLI
     FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL TGKTITLEVE PSDTIENVKA
     KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH LVLRLRGGMQ IFVKTLTGKT
     ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED GRTLSDYNIQ KESTLHLVLR
     LRGGMQIFVK TLTGKTITLE VEPSDTIENV KAKIQDKEGI PPDQQRLIFA GKQLEDGRTL
     SDYNIQKEST LHLVLRLRGG MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ
     QRLIFAGKQL EDGRTLSDYN IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE
     NVKAKIQDKE GIPPDQQRLI FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL
     TGKTITLEVE PSDTIENVKA KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH
     LVLRLRGGMQ IFVKTLTGKT ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED
     GRTLSDYNIQ KESTLHLVLR LRGGV
//
